Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 7, 2001, Pages 388-394

  Hoffman, Jill A ^a   Shah, Ami J ^a   Ross, Lawrence A ^a   Kapoor, Neena ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenoviral infections; Cidofovir; Hematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROBENECID; THYMOCYTE ANTIBODY;

ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; BONE MARROW DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DOSE RESPONSE; DRUG WITHDRAWAL; ENTERITIS; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; INCIDENCE; INFANT; LONG TERM CARE; MALE; MORBIDITY; MORTALITY; NEPHROTOXICITY; PEDIATRIC HOSPITAL; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RECIPIENT; RECURRENT INFECTION; UNITED STATES; VIRUS CULTURE; VIRUS INFECTION; WHOLE BODY RADIATION;

EID: 0034858413     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11529489     Document Type: Article

References (50)

1. Adenoviruses
2. Adenovirus infections in immunocompromised patients
3. Haemorrhagic cystitis in paediatric bone marrow transplant patients: An Association with infective agents, GVHD and prior cyclophosphamide
4. High incidence of adeno-and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine
5. Evolving pathogens in allogeneic bone marrow transplantation: Increased fatal adenoviral infections
6. Adenovirus infections in patients undergoing bone-marrow transplantation
7. Increasing incidence of adenovirus disease in bone marrow transplant recipients
8. Adenovirus infection after pediatric bone marrow transplantation
9. Adenovirus infections in hematopoietic stem cell transplant recipients
10. Viral infections in children undergoing hematopoietic stem cell transplant
11. Adenovirus, parvovirus B19, and papillomavirus
12. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors
13. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin
14. Intravenous ribavirin therapy for adenovirus gastroenteritis in bone marrow transplantation
15. Adenovirus pneumonitis successfully treated with intravenous ribavirin
16. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation
17. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir
18. Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation
19. Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation
20. Adenovirus infections following haematopoietic cell transplantation: Is There a role for adoptive immunotherapy?
21. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
22. In search of a selective antiviral chemotherapy
23. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model
24. Adenovirus cholecystitis in a patient with AIDS
25. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient
26. Adenoviruses in the immunocompromised host
27. Adenoviral infections in children
28. Adenoviral infections in adult recipients of blood and marrow transplants
29. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation
30. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children
31. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease
32. Cytomegalovirus infection after bone marrow transplantation: Association with acute graft-versus-host disease
33. Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia
34. Pretransplant herpesvirus serology and acute graft-versus-host disease
35. Increase in severity of graft versus host disease by cytomegalovirus
36. Incidence of local CMV infection and acute intestinal GVHD in bone marrow transplant recipients with severe diarrhea
37. CMV-viraemia during allogeneic bone marrow transplantation paediatric patients: Association with survival and graft-versus-host-disease
38. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: Evidence of significant relationship
39. Pathogenesis of GVHD: Role of herpes viruses
40. Graft-versus-host disease and cytokines
41. Chronic graft-versus-host disease
42. PCR and restriction endonuclease analysis for rapid identification of human adenovirus subgenera
43. PCR detection of adenovirus in a bone marrow transplant recipient: Hemorrhagic cystitis as a presenting manifestation of disseminated disease
44. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease
45. Use of preemptive ganciclovir based solely on asymptomatic pulmonary cytomegalovirus infection in marrow transplant recipients-long-term follow-up
46. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
47. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic bone marrow transplantation: A randomized double-blind study
48. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients